Cite
MLA Citation
Sergio Iannazzo et al.. “Individualized Treatment of Hbeag-Negative Chronic Hepatitis B Using Pegylated Interferon-α2A as First-Line and Week-12 HBV Dna/Hbsag Stopping Rule: A Cost-Effectiveness Analysis.” Antiviral therapy, vol. 18, no. 4, 2013, pp. 1–11. http://access.bl.uk/ark:/81055/vdc_100170289119.0x000024